ADAM11, ADAM metallopeptidase domain 11, 4185

N. diseases: 42; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1335302
Disease: Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
0.300 GeneticVariation disease UNIPROT
CUI: C0005890
Disease: Body Height
Body Height
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE We recently reported a relationship between plasma levels of cystatin C and incidence of the metabolic syndrome (MetS) among the first 2,369 subjects who participated in the re-examination study of the population-based Malmö and Diet Cancer Cardiovascular cohort (MDC-CC-re-exam). 27218257 2016
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE We recently reported a relationship between plasma levels of cystatin C and incidence of the metabolic syndrome (MetS) among the first 2,369 subjects who participated in the re-examination study of the population-based Malmö and Diet Cancer Cardiovascular cohort (MDC-CC-re-exam). 27218257 2016
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 GeneticVariation group BEFREE A subgroup of the population-based Malmö Diet and Cancer study (MDC-CC) was used as a replication cohort. 25391539 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 GeneticVariation group BEFREE A subgroup of the population-based Malmö Diet and Cancer study (MDC-CC) was used as a replication cohort. 25391539 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 GeneticVariation group BEFREE The VNN1 T26I polymorphism was genotyped in 5664 participants of the cardiovascular cohort of the "Malmö Diet and Cancer" (MDC-CVA) study and successively in 17874 participants of the "Malmö Preventive project"(MPP). 21550219 2013
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 GeneticVariation group BEFREE The VNN1 T26I polymorphism was genotyped in 5664 participants of the cardiovascular cohort of the "Malmö Diet and Cancer" (MDC-CVA) study and successively in 17874 participants of the "Malmö Preventive project"(MPP). 21550219 2013
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.020 GeneticVariation group BEFREE While all vehicle-treated mice died by 19 days of treatment, 7 out of 11 MDC-1112-treated mice were alive and healthy by the end of 5 weeks, with many showing tumor regression. 30994173 2019
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.020 Biomarker disease BEFREE Th2-related chemokines such as thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22), and pro-inflammatory cytokines including interleukin (IL)-1β and IL-6 are considered to play a crucial role in AD. 28958612 2017
CUI: C0013595
Disease: Eczema
Eczema
0.020 Biomarker disease BEFREE Th2-related chemokines such as thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22), and pro-inflammatory cytokines including interleukin (IL)-1β and IL-6 are considered to play a crucial role in AD. 28958612 2017
Squamous cell carcinoma of esophagus
0.020 Biomarker disease BEFREE These studies demonstrated that the exposure of ESCC cells to hypoxia increased the autophagic punctate distribution of MDC staining and GFP-LC3 and that autophagy rate could be inhibited by BNIP3-siRNA. 28859361 2017
Squamous cell carcinoma of esophagus
0.020 GeneticVariation disease BEFREE Logistic regression analyses showed that the MLH1 rs1800734 C>T, SMAD7 rs12953717 C>T and CCL22/MDC rs4359426C>A polymorphisms were not associated with the risk of ESCC in any of the models tested. 29156846 2017
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.020 Biomarker disease BEFREE Chemokines are important mediators of cell migration, and thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22) are well-known typical inflammatory chemokines involved in atopic dermatitis (AD). 24704449 2014
CUI: C0013595
Disease: Eczema
Eczema
0.020 Biomarker disease BEFREE Chemokines are important mediators of cell migration, and thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22) are well-known typical inflammatory chemokines involved in atopic dermatitis (AD). 24704449 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.020 Biomarker group BEFREE The putative tumour suppressor gene MDC (ADAM11) is expressed at very low levels in all cells examined. 9199213 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE Furthermore, the association between DMGV and incident type 2 diabetes mellitus was replicated in both the MDC (hazard ratio=1.83; CI=1.63-2.05; <i>P</i><0.001) and MPP (odds ratio=1.65; CI=1.38-1.98; <i>P</i><0.001). 31533499 2019
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.010 AlteredExpression disease BEFREE The AUC of the 3-signature biosignature (eotaxin, MDC, MCP-1) in differentiating ATB from LTBI was 0.94, with the sensitivity and specificity of 87.76% and 91.84%, respectively. 30528869 2019
CUI: C0151332
Disease: Active tuberculosis
Active tuberculosis
0.010 AlteredExpression disease BEFREE The AUC of the 3-signature biosignature (eotaxin, MDC, MCP-1) in differentiating ATB from LTBI was 0.94, with the sensitivity and specificity of 87.76% and 91.84%, respectively. 30528869 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE CCK-8 assay, EdU staining, flow cytometry, MDC staining, immunofluorescence, transwell migration and invasion assay were used to detect cell proliferation, apoptosis, autophagy, migration and invasion, respectively. 31217869 2019
CUI: C0007113
Disease: Rectal Carcinoma
Rectal Carcinoma
0.010 Biomarker disease BEFREE Our results support the CRC-MDC standard for the National Accreditation Program for Rectal Cancer. 29580878 2018
CUI: C0019559
Disease: Hip joint pain
Hip joint pain
0.010 Biomarker phenotype BEFREE IL6, MDC and IP10 are associated with hip OA pain and these proteins may be able to provide additional information regarding pain in hip OA patients. 29402254 2018
CUI: C0029410
Disease: Osteoarthritis of hip
Osteoarthritis of hip
0.010 Biomarker disease BEFREE IL6, MDC and IP10 are associated with hip OA pain and these proteins may be able to provide additional information regarding pain in hip OA patients. 29402254 2018
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE IL6, MDC and IP10 are associated with hip OA pain and these proteins may be able to provide additional information regarding pain in hip OA patients. 29402254 2018
CUI: C0746025
Disease: Lumbar spondylolisthesis
Lumbar spondylolisthesis
0.010 Biomarker phenotype BEFREE The MDC seems to be a statistically and clinically sound method for defining the appropriate MCID value for patients with grade I degenerative lumbar spondylolisthesis. 29290132 2018